Innovation is of no worth if it doesn’t provide better outcomes for patients. Indeed, such advancements should hold as centre the amelioration of the overall patient experience. And that’s where ...
Pharmaceutical companies approach a significant wave of patent expirations by 2030. This includes exclusivity rights set to expire for 569 medications valued at $278 billion, based on 2022 sales.¹ As ...
ANN ARBOR, Mich. – Resurrecting the Prelude is a loaded proposition. It’s a heady name that carries the weight of history and expectations of a fan base that has specific needs. After a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback